Connection

William Vandergrift to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications William Vandergrift has written about Antineoplastic Combined Chemotherapy Protocols.
William Vandergrift
Connection Strength
0.036
Antineoplastic Combined Chemotherapy Protocols
  1. MGMT-inhibitor in combination with TGF-?RI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells. Clin Transl Oncol. 2021 Mar; 23(3):612-619.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.